Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (492)	3/13/2001 1:00:13 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1784

>> propping up a bar somewhere << Oh, for an evening without the kids!! >> Off to screen for stocks trading at 1.5x cash. 2x is just too crowded at the moment. << Trickle made sense when quality biotechs were trading at large multiples to book, when the downside risk ass'd with quality pipelines was large. It doesn't seem as compelling now, to me. That's why, when I do drop in, I'm neutered......... we've had a long bear market since the concept was floated, and (1) the it hasn't developed (upward) momentum, and (2) there's competition for my fickle affection. It would have been much worse, had Tuck not had the patience and foresight to go slowly, to set entry triggers. I still feel that the portfolio will be a valuable, long-term tool. Ugh. The sector is a toy.